| 18th Jun 2020 7:00 am |
RNS |
PDS & Farmacore Announce Co-Development-PDS0204 |
| 15th Jun 2020 2:41 pm |
RNS |
PDS Announces Initiation of Phase 2 Trial PDS0101 |
| 8th Jun 2020 4:42 pm |
RNS |
Second Price Monitoring Extn |
| 8th Jun 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 5th Jun 2020 9:14 am |
RNS |
PDS Announces Trial of its Lead Product, PDS0101 |
| 1st Jun 2020 7:00 am |
RNS |
Notice of AGM |
| 13th May 2020 2:46 pm |
RNS |
PDS Reports Results for Q1 2020 & Business Update |
| 1st May 2020 11:33 am |
RNS |
Confirmation of Board Changes |
| 30th Apr 2020 12:06 pm |
RNS |
PDS expands CRADA with National Cancer Institute |
| 27th Apr 2020 7:00 am |
RNS |
Preliminary Results for the year ended 31 Dec 2019 |
| 17th Apr 2020 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 17th Apr 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 17th Apr 2020 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 17th Apr 2020 2:00 pm |
RNS |
Price Monitoring Extension |
| 16th Apr 2020 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 16th Apr 2020 4:35 pm |
RNS |
Price Monitoring Extension |
| 16th Apr 2020 2:02 pm |
RNS |
PDS Initiates Programs for COVID-19, PDS0101 delay |
| 14th Apr 2020 7:04 am |
RNS |
PDS Appoints Ilian Iliev to the Board |
| 31st Mar 2020 7:00 am |
RNS |
Board Changes |
| 30th Mar 2020 9:39 am |
RNS |
Holding(s) in Company |
| 14th Feb 2020 3:12 pm |
RNS |
Holding(s) in Company |
| 12th Feb 2020 11:07 am |
RNS |
PDS equity issue and related party transaction |
| 11th Feb 2020 2:24 pm |
RNS |
PDS Biotechnology proposed offering |
| 15th Jan 2020 7:00 am |
RNS |
Board Change |
| 18th Dec 2019 11:24 am |
RNS |
Holding(s) in Company |
| 17th Dec 2019 3:04 pm |
RNS |
Holding(s) in Company |
| 13th Dec 2019 1:21 pm |
RNS |
Board Changes |
| 21st Nov 2019 7:00 am |
RNS |
Glycotest receives 2nd $3m tranche of $10m finance |
| 17th Oct 2019 2:14 pm |
RNS |
Holding(s) in Company |
| 14th Oct 2019 7:00 am |
RNS |
Appointment to the Board |
| 3rd Oct 2019 1:44 pm |
RNS |
PDS collaborates with Merck in Phase 2 studies |
| 1st Oct 2019 2:10 pm |
RNS |
PDS prioritise PDS0101 in high risk HPV to Phase 2 |
| 19th Sep 2019 1:24 pm |
RNS |
PDS - positive data for immunotherapy treatment |
| 19th Sep 2019 11:00 am |
RNS |
Interim Results for six months ended 30 June 2019 |
| 1st Aug 2019 1:44 pm |
RNS |
PDS second quarter 2019 financial results |
| 31st Jul 2019 8:41 am |
RNS |
PDS Biotechnology Corp liquidity funding program |
| 9th Jul 2019 2:58 pm |
RNS |
Holding(s) in Company |
| 8th Jul 2019 4:04 pm |
RNS |
Holding(s) in Company |
| 18th Jun 2019 2:27 pm |
RNS |
Result of Annual General Meeting |
| 31st May 2019 7:00 am |
RNS |
Positive new data demonstrates NEATstiks potential |
